This week’s Research Ethics Roundup explores ethical issues related to the conduct of research in resource-limited settings and reproducibility, as well as issues related to the development of Ebola treatments. Read on to find out more and discover what’s happening in the world of research ethics and oversight.
A Failed Trial in Africa Raises Questions About How to Test HIV Drugs: Donald J. McNeil Jr. reports on a clinical trial that was recently halted in South Africa, Zimbabwe, and Uganda in this article for The New York Times. The failed trial, which sought to evaluate [...] Read more
by Rebecca S. Ohnemus, MAA, CRA, Research Officer at University of the Incarnate Word
PRIM&R is pleased to share a post by Rebecca Ohnemus, MAA, CRA, a member of the PRIM&R Blog Squad for the 2014 Advancing Ethical Research (AER) Conference. The PRIM&R Blog Squad is composed [...] Read more
Perhaps you’ve already read – on your Facebook News Feed, no doubt – about Facebook’s recent mood experiment. Not to worry—this post has no hidden motive. We’re just pleased to be able to share recent headlines from around the research ethics world with you.
Everything We Know about Facebook’s Secret Mood Manipulation Experiment: Following the publication of a paper in the Proceedings of the National Academy of Sciences, [...] Read more
As winter soldiers on and you recover from the post-Olympic slump, spend some time catching up with what has been happening in the research ethics world:
NIH [...] Read more
Whether you have the time now, or need to bookmark this site for later, take a few minutes to catch up with the latest news in the research ethics world!
Treating Kids’ Cancer with Science and a Pocket Full of Hope: Pediatric brain cancer researcher Jim Olsen is developing an experimental product called Tumor Paint, a molecule that includes a dye that makes tumor cells glow during brain surgery. The goal is to make tumors easier for surgeons to remove. The first tests of Tumor Paint are scheduled for later this year.